publication venue for
- Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force.. 27:692-701. 2024
- Patient-Reported Outcome-Based Performance Measures in Alternative Payment Models: Current Use, Implementation Barriers, and Principles to Succeed.. 27:199-205. 2023
- Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials.. 25:1268-1280. 2022
- Cost-Effectiveness of the Wellness Incentives and Navigation (WIN) Program.. 24:361-368. 2020
- Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim Products.. 23:1599-1605. 2020
- Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments.. 23:616-624. 2020
- Long-Term Health and Economic Value of Improved Mobility among Older Adults in the United States.. 21:792-798. 2018
- Estimating an EQ-5D-5L Value Set for China.. 20:662-669. 2017
- Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis.. 19:631-8. 2016
- Chinese time trade-off values for EQ-5D health states.. 17:597-604. 2014
- Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach.. 13:338-45. 2010
- Implantable or external defibrillators for individuals at increased risk of cardiac arrest: where cost-effectiveness hits fiscal reality.. 9:292-302. 2006
- Out-of-pocket health-care expenditures among older Americans with cancer.. 7:186-94. 2004